Evaluation of Postoperative Adhesions in a Subsequent Cesarean Section Following the Use of Dextrin Hydrogel Spray As Adhesion Barrier for Laparoscopic Myomectomy

Overview

Journal Gynecol Minim Invasive Ther

Date 2024 Dec 11

PMID 39660231

Authors

Shinichiro Wada

Yoshiyuki Fukushi

Tomono Shimabukuro

Sachiko Matsumoto

Mai Nishimura

Makiko Nakatani

Ayako Nakajima

Affiliations

Soon will be listed here.

Abstract

Objectives: Laparoscopic myomectomy (LM) is a procedure with a high rate of postoperative adhesions, which can lead to complications such as bowel obstruction and subsequent surgical problems, making anti-adhesion measures important. Various anti-adhesion materials are already on the market and have shown efficacy, but dextrin hydrogel spray (AdSpray™), an anti-adhesion material launched in 2017, has not yet been reported in the field of gynecology, although there are papers showing its usefulness in the surgical field such as repeat hepatectomy and ileostomy closure. Thereby, we investigated the postoperative status of AdSpray™ in LM.

Materials And Methods: We report 24 cases in which AdSpray™ was used at Teine Keijinkai Hospital from 2018 to 2021 for LM, followed by cesarean section (CS) from 2019 to 2022. Adverse effects related to AdSpray™ and the presence of uterine adhesions in CS were examined.

Results: Adhesions were observed in 4 (16.7%) cases, none of which resulted in significant adverse effects of AdSpray™.

Conclusion: AdSpray™ was effective in preventing adhesion and may be an option as an anti-adhesion material in LM.

References

Tang J, Xiang Z, Bernards M, Chen S . Peritoneal adhesions: Occurrence, prevention and experimental models. Acta Biomater. 2020; 116:84-104. DOI: 10.1016/j.actbio.2020.08.036. View

Cezar C, Korell M, Tchartchian G, Ziegler N, Senshu K, Herrmann A . How to avoid risks for patients in minimal-access trials: Avoiding complications in clinical first-in-human studies by example of the ADBEE study. Best Pract Res Clin Obstet Gynaecol. 2015; 35:84-96. DOI: 10.1016/j.bpobgyn.2015.11.004. View

Kai M, Maeda K, Tasaki M, Kira S, Nakamura S, Chino N . Evaluation of a Spray-type, Novel Dextrin Hydrogel Adhesion Barrier Under Laparoscopic Conditions in a Porcine Uterine Horn Adhesion Model. J Minim Invasive Gynecol. 2017; 25(3):447-454. DOI: 10.1016/j.jmig.2017.09.023. View

Kotani Y, Tobiume T, Fujishima R, Shigeta M, Takaya H, Nakai H . Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy. J Obstet Gynaecol Res. 2017; 44(2):298-302. PMC: 5836951. DOI: 10.1111/jog.13519. View

Tinelli A, Malvasi A, Guido M, Tsin D, Hudelist G, Hurst B . Adhesion formation after intracapsular myomectomy with or without adhesion barrier. Fertil Steril. 2011; 95(5):1780-5. DOI: 10.1016/j.fertnstert.2010.12.049. View

Cezar C, Tchartchian G, Korell M, Ziegler N, Senshu K, de Wilde M . Long term follow-up concerning safety and efficacy of novel adhesion prophylactic agent for laparoscopic myomectomy in the prospective randomized ADBEE study. Best Pract Res Clin Obstet Gynaecol. 2016; 35:97-112. DOI: 10.1016/j.bpobgyn.2016.06.003. View

Herrmann A, Torres-de la Roche L, Krentel H, Cezar C, de Wilde M, Devassy R . Adhesions after Laparoscopic Myomectomy: Incidence, Risk Factors, Complications, and Prevention. Gynecol Minim Invasive Ther. 2020; 9(4):190-197. PMC: 7713662. DOI: 10.4103/GMIT.GMIT_87_20. View

Mais V, Ajossa S, Piras B, Guerriero S, Marongiu D, Melis G . Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier. Hum Reprod. 1995; 10(12):3133-5. DOI: 10.1093/oxfordjournals.humrep.a135873. View

Zuhlke H, Lorenz E, Straub E, Savvas V . [Pathophysiology and classification of adhesions]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990; :1009-16. View

10.

Okubo S, Shindoh J, Kobayashi Y, Matsumura M, Hashimoto M . Adhesions as a risk factor for postoperative morbidity in patients undergoing repeat hepatectomy and the potential efficacy of adhesion barriers. J Hepatobiliary Pancreat Sci. 2021; 29(6):618-628. DOI: 10.1002/jhbp.1047. View

11.

Suto T, Watanabe M, Endo T, Komori K, Ohue M, Kanemitsu Y . The Primary Result of Prospective Randomized Multicenter Trial of New Spray-Type Bio-absorbable Adhesion Barrier System (TCD-11091) Against Postoperative Adhesion Formation. J Gastrointest Surg. 2017; 21(10):1683-1691. PMC: 5610222. DOI: 10.1007/s11605-017-3503-1. View

12.

Ten Broek R, Stommel M, Strik C, van Laarhoven C, Keus F, Goor H . Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet. 2013; 383(9911):48-59. DOI: 10.1016/S0140-6736(13)61687-6. View

13.

Ahmad G, Kim K, Thompson M, Agarwal P, OFlynn H, Hindocha A . Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2020; 3:CD000475. PMC: 7085418. DOI: 10.1002/14651858.CD000475.pub4. View